Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2026)
Cytek Biosciences posted quarterly Non Operating Investment Income of -$201000.0 for Q1 2026, down 209.23% year-on-year from $184014.1 in Q1 2025, and down 628.95% on a QoQ basis from $38000.0 in Q4 2025.
Cytek Biosciences (CTKB) has 5 years of Non Operating Investment Income data on file, last reported at -$201000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Investment Income fell 209.23% year-over-year to -$201000.0; the trailing twelve-month figure through Mar 2026 stood at -$78000.0 (down 216.42% YoY), and the FY2025 full-year result was $58000.0, down 40.21% from the prior year.
- Non Operating Investment Income for Q1 2026 stood at -$201000.0, down from $38000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $195000.0 in Q3 2024 and bottomed at -$201000.0 in Q1 2026.
- The 5-year median for Non Operating Investment Income is -$9500.0 (2023), against an average of -$4071.4.
- Peak annual rise in Non Operating Investment Income reached 1200.0% in 2024, while the deepest fall reached 1466.67% in 2024.
- A 5-year view of Non Operating Investment Income shows it stood at $17000.0 in 2022, then tumbled by 117.65% to -$3000.0 in 2023, then slumped by 1466.67% to -$47000.0 in 2024, then jumped by 180.85% to $38000.0 in 2025, then sank by 628.95% to -$201000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$201000.0 (Q1 2026), $38000.0 (Q4 2025), and $118000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -201,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Sep 30, 2025 | 118,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | -192,000.00 |
| Jun 30, 2023 | -192,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |